Antibiotic Development Hinges On Financial Incentives, Experts Tell Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Janet Woodcock supports streamlining approval of antibiotics but says it won’t solve problem of industry investment; others point to BARDA as model for government funding.